The Centers for Disease Control & Prevention’s Advisory Committee on Immunization Practices released the 2019 child and adolescent immunization schedules—approved by AAFP—on February 5. Included are changes to recommendations for influenza, hepatitis A and B, and Tdap vaccines.
- Intranasal live attenuated influenza vaccine (LAIV) is once again added as an option for children 24 months old and older.
- Guidance is included for vaccinating people with a history of egg allergies, as well as when not to administer LAIV.
- Children 6-11 months old, as well as unvaccinated people aged 12 months and older, should receive the hepatitis A vaccine before international travel.
- Homelessness was added as an indication for vaccinating against hepatitis A.
- A wording change was made to emphasize the importance of administering the first dose of hepatitis B to every medically stable infant who weighs 2,000 grams or more who is born to a mother who is hepatitis B surface antigen negative.
- Those who received a dose of Tdap or DTaP at 7-10 years of age inadvertently or as part of the catch-up schedule should receive the routine dose of Tdap at 11-12 years of age.